Xavier Castellsagué

1992–2022 年に発表

119
論文数
45,833
被引用数
95
h 指数
119
i10 指数

被引用数

Xavier Castellsagué の年別被引用数1992 年: 被引用 3 件1993 年: 被引用 4 件1994 年: 被引用 2 件1995 年: 被引用 7 件1996 年: 被引用 10 件1997 年: 被引用 14 件1998 年: 被引用 14 件1999 年: 被引用 11 件2000 年: 被引用 19 件2001 年: 被引用 12 件2002 年: 被引用 50 件2003 年: 被引用 83 件2004 年: 被引用 83 件2005 年: 被引用 153 件2006 年: 被引用 191 件2007 年: 被引用 227 件2008 年: 被引用 287 件2009 年: 被引用 286 件2010 年: 被引用 317 件2011 年: 被引用 381 件2012 年: 被引用 404 件2013 年: 被引用 393 件2014 年: 被引用 343 件2015 年: 被引用 463 件2016 年: 被引用 328 件2017 年: 被引用 430 件2018 年: 被引用 345 件2019 年: 被引用 1,318 件2020 年: 被引用 1,197 件2021 年: 被引用 1,075 件2022 年: 被引用 763 件2023 年: 被引用 550 件2024 年: 被引用 751 件2025 年: 被引用 326 件2026 年: 被引用 8 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,859 件、この内訳の 20%中国: 引用元論文 982 件、この内訳の 6.9%イギリス: 引用元論文 945 件、この内訳の 6.6%フランス: 引用元論文 684 件、この内訳の 4.8%ドイツ: 引用元論文 564 件、この内訳の 3.9%イタリア: 引用元論文 557 件、この内訳の 3.9%カナダ: 引用元論文 509 件、この内訳の 3.5%スペイン: 引用元論文 502 件、この内訳の 3.5%オランダ: 引用元論文 495 件、この内訳の 3.5%オーストラリア: 引用元論文 426 件、この内訳の 3%インド: 引用元論文 332 件、この内訳の 2.3%ブラジル: 引用元論文 317 件、この内訳の 2.2%
0%20%その他 35.9%

分野

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Immunology and Microbiology4.3%
  • Dentistry1.5%
  • Health Professions1.2%
  • Social Sciences0.7%
  • その他4.2%

トピック

  • Cervical Cancer and HPV Research17.2%
  • Head and Neck Cancer Studies7.8%
  • Genital Health and Disease4.1%
  • Hepatitis B Virus Studies3.4%
  • Reproductive tract infections research3.3%
  • Endometrial and Cervical Cancer Treatments3%
  • その他61.2%

共著者

全論文

検索で開く
  1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clara Menéndez, Efrén Javier Domingo, Julio Velasco, Ashrafun Nessa, Saibua C Bunnag Chichareon, You‐Lin Qiao, Enrique Lerma, Suzanne M. Garland, Toshiyuki Sasagawa, Annabelle Ferrera, Doudja Hammouda, Luciano Mariani, Adela Pelayo, I Steiner, Esther Oliva, Chris J.L.M. Meijer, Waleed Al-Jassar, Eugénia Cruz, Thomas C. Wright, A Puras, Cecilia Llave, Maria Tzardi, Θεόδωρος Αγοραστός, Victoria García-Barriola, Christine Clavel, Jaume Ordï, Miguel Andújar, Xavier Castellsagué, Gloria Inés Sánchez, Andrzej Nowakowski, Jacob Bornstein, Nubia Muñóz, F. Xavier Bosch - The Lancet Oncology 2010 被引用: 2,728

  2. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

    著者: , , , , , , , - New England Journal of Medicine 2003 被引用: 6,297

  3. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

    著者: , , , , , - The Journal of Infectious Diseases 2010 被引用: 1,630

  4. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

    著者: , , , , , , , - The Lancet Global Health 2016 被引用: 827

  5. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

    著者: , , , , , , - The Lancet Infectious Diseases 2007 被引用: 1,669

  6. Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches

    著者: , , , - Dermatology and Therapy 2017 被引用: 461

  7. Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen M. Schwartz, Elaine Smith, Erich M. Sturgis, Neonilia Szeszenia‐Dabrowska, Renato Talamini, Qingyi Wei, Deborah M. Winn, Oxana Shangina, Agnieszka Pilarska, Zuo‐Feng Zhang, Gilles Ferro, Julien Berthiller, Paolo Boffetta - Cancer Epidemiology Biomarkers & Prevention 2009 被引用: 1,244

  8. A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

    著者: , , - Vaccine 2012 被引用: 742

  9. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis

    著者: , , , , , , , , - The Lancet Oncology 2014 被引用: 729

  10. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oluseyi F. Ajayi, Flora Duarte, Ashrafun Nessa, Leopoldo Tinoco, Marco A. Durán-Padilla, Edyta C. Pirog, Halina Viarheichyk, Hesler Morales, Valérie Costes, Ana Félix, Maria Julieta V. Germar, M. Mena, Arzu Ruacan, Asha Jain, Ravi Mehrotra, Marc T. Goodman, Luis Estuardo Lombardi, Annabelle Ferrera, Sani Malami, Estela I. Albanesi, Pablo Dabed, Carla Molina, Rubén López‐Revilla, Václav Mandys, Manuel González, Julio Velasco, Ignacio G. Bravo, Wim Quint, Michael Pawlita, Núbia Muñóz, Silvia de Sanjosé, F. Xavier Bosch - JNCI Journal of the National Cancer Institute 2016 被引用: 752

  11. Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. M. Winn, Давид Заридзе, Witold Zatoński, Zuo‐Feng Zhang, J. Berthiller, P. Boffetta - JNCI Journal of the National Cancer Institute 2007 被引用: 1,110

  12. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2009 被引用: 1,655

  13. Natural history and epidemiology of HPV infection and cervical cancer

    著者: - Gynecologic Oncology 2008 被引用: 594

  14. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 703

  15. Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard B. Hayes, Silvia Franceschi, Victor Wünsch-Filho, Leticia Fernandez, Eleonora Fabianova, Alexander W. Daudt, Luigino Dal Maso, María Paula Curado, Chu Chen, Xavier Castellsagué, Marcos Brasilino de Carvalho, Gabriella Cadoni, Stefania Boccia, Paul Brennan, Paolo Boffetta, A.F. Olshan - American Journal of Epidemiology 2013 被引用: 302

  16. Chapter 1: HPV in the etiology of human cancer

    著者: , , , - Vaccine 2006 被引用: 1,368

  17. Comprehensive Control of Human Papillomavirus Infections and Related Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Vaccine 2013 被引用: 440

  18. Role of Human Papillomavirus in Penile Carcinomas Worldwide

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jose D. Mota, Robert Jach, Julio Velasco, Carla Carrilho, Rubén López‐Revilla, Marc T. Goodman, Wim Quint, Xavier Castellsagué, Ignacio G. Bravo, Michael Pawlita, Nubia Muñóz, F. Xavier Bosch, Silvia de Sanjosé - European Urology 2016 被引用: 293

  19. Worldwide burden of cervical cancer in 2008

    著者: , , , , , , - Annals of Oncology 2011 被引用: 1,147

  20. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 507

  21. Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Petra H. Peeters, Eiliv Lund, Elisabete Weiderpass, María Luisa Redondo, María‐José Sánchez, María-José Tormo, Aurelio Barricarte, Nerea Larrañaga, Johanna Ekström, Maria Hortlund, David Lindquist, Nick Wareham, Ruth C. Travis, Sabina Rinaldi, Massimo Tommasino, Silvia Franceschi, Elio Ríboli - International Journal of Cancer 2013 被引用: 291

  22. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eiliv Lund, Petra H. Peeters, H. B. Bueno-de-Mesquita, J. Ramón Quirós, María‐José Sánchez, Carmen Navarro, Aurelio Barricarte, Nerea Larrañaga, Johanna Ekström, David Lindquist, Annika Idahl, Ruth C. Travis, Melissa A. Merritt, Marc J. Gunter, Sabina Rinaldi, Massimo Tommasino, Silvia Franceschi, Elio Ríboli, Xavier Castellsagué - PLoS ONE 2016 被引用: 209

  23. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2007 被引用: 1,315

  24. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

    著者: , , , , , , , , , , , , , - British Journal of Cancer 2011 被引用: 346